Eli Lily reported that the drug helped people with diabetes who were overweight or had obesity lose up to 16% of their body weight over 17 months in a late-stage trial.
ABC News chief medical correspondent Dr. Alok Patel breaks down all you need to know about Mounjaro and the safety precautions surrounding it.
Having diabetes makes it notoriously difficult to lose weight, said Dr. Nadia Ahmad, Lilly's medical director of obesity clinical development, which means the recent results are especially significant. "We have not seen this degree of weight reduction," she said. Industry analysts predict that tirzepatide could become one of the top-selling drugs ever, with annual sales topping $50 billion. It is expected to outpace Novo Nordisk's Ozempic -- a diabetes drug used so commonly to shed pounds that comedian Jimmy Kimmel joked about it at the Oscars -- and Wegovy, a version of the drug also known as semaglutide approved for weight loss in 2021.
"Psychologically, you don't want to eat," said Barlow. "Now I can eat two bites of a dessert and be satisfied." The obesity medications help overcome a biological mechanism that kicks in when people diet, triggering a coordinated effort by the body to prevent weight loss. Though the drugs appear safe, they can cause side effects, some serious. Most common reactions include diarrhea, nausea, vomiting, constipation and stomach pain. Some users have developed pancreatitis or inflammation of the pancreas, others have had gallbladder problems. Mounjaro's product description warns that it could cause thyroid tumors, including cancer.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly Pushes For Fast-Track Approval Of Mounjaro As Weight-Loss DrugLate-stage trials suggest Lilly’s tirzepatide, sold under Mounjaro, could be a more effective obesity drug that Ozempic or Wegovy, and the company expects a regulatory decision by the end of the year.
Read more »
Popular diabetes drug Mounjaro could be FDA-approved for weight loss this year, company saysA popular drug currently approved to treat Type 2 diabetes could soon also be approved for weight loss.
Read more »
Mounjaro Helps Diabetes Patients Lose ‘Meaningful’ Weight, Study ShowsMounjaro might be the next drug—after Ozempic—to upend the weight-loss market after a study showed it helped overweight and obese patients with Type 2 diabetes lose up to 15.7% of their body weight
Read more »
Mounjaro: Powerful new obesity drug poised to upend weight loss careEli Lily reported that the drug helped people with diabetes who were overweight or had obesity lose up to 16% of their body weight over 17 months in a late-stage trial.
Read more »
Mounjaro: Powerful new obesity drug poised to upend weight loss careEli Lily reported that the drug helped people with diabetes who were overweight or had obesity lose up to 16% of their body weight over 17 months in a late-stage trial.
Read more »
Mounjaro: Powerful new obesity drug poised to upend weight loss careEli Lily reported that the drug helped people with diabetes who were overweight or had obesity lose up to 16% of their body weight over 17 months in a late-stage trial.
Read more »